Nevertheless, it has been shown that intrinsic IGFBP2 interacts with integrin α5β1 and promotes migration of glioma cells and glioma progression through activation of AKT, ILK, and NF-κB pathways[7,8,20]. The gene discussed is ILK; the disease is central nervous system cancer.